Literature DB >> 18538661

UV as an amplifier rather than inducer of NF-kappaB activity.

Ellen L O'Dea1, Jeffrey D Kearns, Alexander Hoffmann.   

Abstract

Inflammatory activation of NF-kappaB involves the stimulus-induced degradation of the NF-kappaB-bound inhibitor IkappaB via the IkappaB kinase (IKK). In response to UV irradiation, however, the mechanism and function of NF-kappaB activation remain unclear. Using a combined biochemical, genetic, and computational modeling approach, we delineate a dual requirement for constitutive IKK-dependent and IKK-independent IkappaB degradation pathways in conjunction with UV-induced translational inhibition. Interestingly, we find that the high homeostatic turnover of IkappaB in resting cells renders the NF-kappaB system remarkably resistant to metabolic stresses, but the two degradation pathways critically and differentially tune NF-kappaB responsiveness to UV. Indeed, in the context of low chronic inflammation that accelerates NF-kappaB-bound IkappaB degradation, UV irradiation results in dramatic NF-kappaB activation. Our work suggests that the human health relevance of NF-kappaB activation by UV lies with cellular homeostatic states that are associated with pathology rather than with healthy physiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538661      PMCID: PMC2682114          DOI: 10.1016/j.molcel.2008.03.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  28 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

Review 2.  Translational control of gene expression during hypoxia.

Authors:  Twan van den Beucken; Marianne Koritzinsky; Bradly G Wouters
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

Review 3.  Physicochemical modelling of cell signalling pathways.

Authors:  Bree B Aldridge; John M Burke; Douglas A Lauffenburger; Peter K Sorger
Journal:  Nat Cell Biol       Date:  2006-11       Impact factor: 28.824

4.  A fourth IkappaB protein within the NF-kappaB signaling module.

Authors:  Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl F Ware; Gourisankar Ghosh; Inder M Verma; Alexander Hoffmann
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

5.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

6.  NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta.

Authors:  Jing Liu; Dan Yang; Yuzuru Minemoto; Michael Leitges; Marsha R Rosner; Anning Lin
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

Review 7.  Coping with stress: eIF2 kinases and translational control.

Authors:  R C Wek; H-Y Jiang; T G Anthony
Journal:  Biochem Soc Trans       Date:  2006-02       Impact factor: 5.407

8.  IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression.

Authors:  Jeffrey D Kearns; Soumen Basak; Shannon L Werner; Christine S Huang; Alexander Hoffmann
Journal:  J Cell Biol       Date:  2006-05-30       Impact factor: 10.539

9.  A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity.

Authors:  Ellen L O'Dea; Derren Barken; Raechel Q Peralta; Kim T Tran; Shannon L Werner; Jeffrey D Kearns; Andre Levchenko; Alexander Hoffmann
Journal:  Mol Syst Biol       Date:  2007-05-08       Impact factor: 11.429

Review 10.  Role of proteasomes in disease.

Authors:  Burkhardt Dahlmann
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more
  50 in total

Review 1.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

2.  Anatomy of a negative feedback loop: the case of IκBα.

Authors:  Riku Fagerlund; Marcelo Behar; Karen T Fortmann; Y Eason Lin; Jesse D Vargas; Alexander Hoffmann
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

Review 3.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

4.  Pre-folding IkappaBalpha alters control of NF-kappaB signaling.

Authors:  Stephanie M E Truhlar; Erika Mathes; Carla F Cervantes; Gourisankar Ghosh; Elizabeth A Komives
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

5.  The nanny model for IDPs.

Authors:  Peter Tsvetkov; Nina Reuven; Yosef Shaul
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

6.  Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response.

Authors:  Peter Tsvetkov; Nina Reuven; Carol Prives; Yosef Shaul
Journal:  J Biol Chem       Date:  2009-07-17       Impact factor: 5.157

Review 7.  Ubiquitination and degradation of the inhibitors of NF-kappaB.

Authors:  Naama Kanarek; Nir London; Ora Schueler-Furman; Yinon Ben-Neriah
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 8.  The regulatory logic of the NF-kappaB signaling system.

Authors:  Ellen O'Dea; Alexander Hoffmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

9.  IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Authors:  Jun-Ming Liao; Yu Zhang; Wenjuan Liao; Sheyla X Zeng; Xiaohua Su; Elsa R Flores; Hua Lu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

10.  The IkappaBalpha/NF-kappaB complex has two hot spots, one at either end of the interface.

Authors:  Simon Bergqvist; Gourisankar Ghosh; Elizabeth A Komives
Journal:  Protein Sci       Date:  2008-09-29       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.